Agalsidase Beta Clinical Trials

• Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
  ClinicalTrials.gov Identifier: NCT00487630 - Recruiting
  Fabry Disease
  
• A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients with Cardiac Fabry Disease.
  ClinicalTrials.gov Identifier: NCT00140621 - Recruiting
  cardiac fabry disease
  
• Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
  ClinicalTrials.gov Identifier: NCT00493116 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Extension Study on Efficacy and Safety of Deferasirox Treatment in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
  ClinicalTrials.gov Identifier: NCT00171301 - Active, not recruiting
  Beta-Thalassemia Major
  
• Genetic Factors Affecting the Severity of Beta Thalassemia
  ClinicalTrials.gov Identifier: NCT00159042 - Recruiting
  beta Thalassemia
  
• Study of Protein Translocation in Patients With Beta-Oxidation Disorders
  ClinicalTrials.gov Identifier: NCT00004348 - Active, not recruiting
  Beta-Oxidation Disorder; Peroxisomal Disorders
  
• Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
  ClinicalTrials.gov Identifier: NCT00162565 - Recruiting
  Heart Failure,Congestive; beta-Adrenergic Blockers
  
• Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
  ClinicalTrials.gov Identifier: NCT00562172 - Recruiting
  Type 2 Diabetes Mellitus
  
• A Study of the Safety and Efficacy of Fabrazyme as Compared to Placebo in Patients with Advanced Fabry Disease
  ClinicalTrials.gov Identifier: NCT00074984 - Completed
  Fabry Disease
  
• Combined Chelation Treatment with Deferiprone and Deferoxamine in Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00103753 - Active, not recruiting
  beta-Thalassemia
  
• A Study of the Safety and Efficacy of Fabrazyme in Patients with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00074971 - Completed
  Fabry Disease
  
• A Study of the Safety and Efficacy of Fabrazyme in Patients with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00081497 - Completed
  Fabry Disease
  
• A Study of Fabrazyme in Pediatric Patients with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00074958 - Completed
  Fabry Disease
  
• Cardiac T2* in Beta-Thalassemia Patients on Deferasirox Treatment
  ClinicalTrials.gov Identifier: NCT00447694 - Recruiting
  Beta-Thalassemia; Iron Overload
  
• Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00336362 - Recruiting
  Beta-Thalassemia
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with HIV infection and modestly detectable viral load.
  ClinicalTrials.gov Identifier: NCT00040157 - Active, not recruiting
  HIV Infections
  
• Beta Alethine in Treating Patients With Low-Grade Lymphoma
  ClinicalTrials.gov Identifier: NCT00007839 - Active, not recruiting
  Lymphoma
  
• Safety Study of Interferon Beta 1a to for Acute Stroke
  ClinicalTrials.gov Identifier: NCT00097318 - Active, not recruiting
  Cerebrovascular Accident
  
• Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
  ClinicalTrials.gov Identifier: NCT00474838 - Recruiting
  Type 2 Diabetes Mellitus; Pancreatic Beta Cell Function; Glucotoxicity
  
• Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00409084 - Recruiting
  Esophageal Varices
  
• Randomized Trial of Beta-Carotene and Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00000152 - Active, not recruiting
  Macular Degeneration
  
• Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00041379 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with chronic Hepatitis B infection.
  ClinicalTrials.gov Identifier: NCT00037622 - Active, not recruiting
  Chronic Hepatitis B
  
• Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
  ClinicalTrials.gov Identifier: NCT00414193 - Recruiting
  Bacteremia; AmpC Beta-Lactamase
  
• Hu-Mik-(Beta)1 to Treat T-Cell Large Granular Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00076180 - Recruiting
  Leukemia, T-Cell
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
  ClinicalTrials.gov Identifier: NCT00151801 - Recruiting
  Multiple Sclerosis
  
• Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-Thalassaemia Patients) With Chronic Iron Overload
  ClinicalTrials.gov Identifier: NCT00564941 - Not yet recruiting
  Myelodysplastic Syndromes; Beta-Thalassemia
  
• Long-Acting Beta Agonist Response by Genotype
  ClinicalTrials.gov Identifier: NCT00200967 - Active, not recruiting
  Asthma
  
• Effects of (1,3), (1,6)-Beta-D-Glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00403689 - Active, not recruiting
  Overweight
  
• A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
  ClinicalTrials.gov Identifier: NCT00413101 - Active, not recruiting
  Anemia
  
• Elder Surgery - Functional Recovery Following Beta Blockade
  ClinicalTrials.gov Identifier: NCT00507663 - Active, not recruiting
  Post Operative Cognitive Dysfunction
  
• Beta-Carotene and Alpha-Tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00169845 - Active, not recruiting
  Neoplasms
  
• Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
  ClinicalTrials.gov Identifier: NCT00492466 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Interferon-beta Treatment of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00048347 - Recruiting
  Ulcerative Colitis
  
• Beta Alethine in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00006466 - Active, not recruiting
  monoclonal gammopathy of undetermined significance; stage I multiple myeloma; stage II multiple myeloma; extramedullary plasmacytoma; ...
  
• Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
  ClinicalTrials.gov Identifier: NCT00115349 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Thalassemia; Anemia (Cooley''s); beta-Thalassemia
  
• Surveillance of Streptococcal Infections in Children in India
  ClinicalTrials.gov Identifier: NCT00342199 - Active, not recruiting
  Group A Beta Hemolytic Streptococcal (GAS) Infection
  
• The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
  ClinicalTrials.gov Identifier: NCT00174902 - Active, not recruiting
  Arteriosclerosis; Stress, Psychological
  
• Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
  ClinicalTrials.gov Identifier: NCT00204074 - Active, not recruiting
  Migraine
  
• Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
  ClinicalTrials.gov Identifier: NCT00520377 - Active, not recruiting
  Alveolar Ridge Augmentation
  
• Safety & Efficacy of ICL670 vs. deferoxamine in Beta-thalassemia patients with iron overload due to blood transfusions
  ClinicalTrials.gov Identifier: NCT00061750 - Completed
  beta-Thalassemia
  
• Luteal Phase FSH in the IVF Poor Reponder
  ClinicalTrials.gov Identifier: NCT00225433 - Active, not recruiting
  Infertility
  
• A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00303589 - Active, not recruiting
  Soft Tissue Infections
  
• Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
  ClinicalTrials.gov Identifier: NCT00569023 - Enrolling by invitation
  Night Blindness
  
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  ClinicalTrials.gov Identifier: NCT00342992 - Active, not recruiting
  Lung Cancer; Prostatic Neoplasms; Prostate Cancer; Pancreatic Cancer
  
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
  ClinicalTrials.gov Identifier: NCT00551291 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Beta Blockade in Critical Injury
  ClinicalTrials.gov Identifier: NCT00356187 - Recruiting
  Trauma
  
• Beta-Blocker Before Extubation
  ClinicalTrials.gov Identifier: NCT00563238 - Recruiting
  Myocardial Ischemia
  
• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00087009 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Beta-2 Polymorphisms and Beta Receptor Selectivity
  ClinicalTrials.gov Identifier: NCT00214318 - Completed
  Heart Failure
  
• Beta Blocker for Chronic Wound Healing
  ClinicalTrials.gov Identifier: NCT00368602 - Recruiting
  Ulcer; Burns
  
• Beta Cell Function in Women With Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00419107 - Active, not recruiting
  Turner Syndrome
  
• Beta-Cell Function and Sitagliptin Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00420511 - Recruiting
  Type 2 Diabetes Mellitus
  
• Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00544453 - Active, not recruiting
  Alzheimer Disease
  
• Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS
  ClinicalTrials.gov Identifier: NCT00168766 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Gene Expression in MS Patients Before and During Treatment With Interferon-Beta
  ClinicalTrials.gov Identifier: NCT00202384 - Recruiting
  Multiple Sclerosis
  
• BOAT: Beta Blocker Uptitration With OptiVol After CRT.
  ClinicalTrials.gov Identifier: NCT00433043 - Recruiting
  Congestive Heart Failure
  
• Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
  ClinicalTrials.gov Identifier: NCT00437450 - Active, not recruiting
  Anemia in Myelodysplastic Syndromes
  
• Physicians' Health Study II: Vitamin E, Ascorbic Acid, Beta Carotene, and/or Multivitamins in Preventing Cancer and Cardiovascular Disease in Older Healthy Male Doctors
  ClinicalTrials.gov Identifier: NCT00270647 - Active, not recruiting
  Colorectal Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00574405 - Recruiting
  Diabetes Mellitus
  
• Collaborative Initial Glaucoma Treatment Study (CIGTS)
  ClinicalTrials.gov Identifier: NCT00000149 - Active, not recruiting
  Open-Angle Glaucoma
  
• Effect of AC2993 with or without Immunosuppression on Beta Cell Function in Patients with Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00064714 - Active, not recruiting
  Diabetes Mellitus
  
• Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
  ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• Minocycline as Add-on to Interferon-Beta-1a (Rebif®) in RRMS (Recycline)
  ClinicalTrials.gov Identifier: NCT00381459 - Recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Epidemiology of Community - Associated Extended-Spectrum Beta-Lactamases (ESBL) Producing Escherichia Coli
  ClinicalTrials.gov Identifier: NCT00573235 - Recruiting
  Enterobacteriaceae Infections
  
• Preservation of Beta-Cell Function in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00232583 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00420290 - Recruiting
  End Stage Renal Disease
  
• Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
  ClinicalTrials.gov Identifier: NCT00001958 - Completed
  Beta Thalassemia; Hemoglobinopathy
  
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00367055 - Active, not recruiting
  Type 2 Diabetes
  
• Randomized Trials of Vitamin Supplements and Eye Disease
  ClinicalTrials.gov Identifier: NCT00000161 - Active, not recruiting
  Macular Degeneration; Cataract
  
• Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
  ClinicalTrials.gov Identifier: NCT00573521 - Recruiting
  Enterobacteriaceae Infections
  
• A Study of the Efficacy and Safety of Genz-112638 in Type 1 Gaucher Patients
  ClinicalTrials.gov Identifier: NCT00358150 - Active, not recruiting
  Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
  
• Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients
  ClinicalTrials.gov Identifier: NCT00263380 - Recruiting
  COPD
  
• Use of Beta Blockers in Elderly Trauma Patients
  ClinicalTrials.gov Identifier: NCT00302692 - Recruiting
  Multiple Trauma; Cardiovascular Diseases; Aged
  
• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00492167 - Recruiting
  Neuroblastoma
  
• Early Diagnosis of Candida Infections in Premature Infants
  ClinicalTrials.gov Identifier: NCT00109525 - Recruiting
  Candidiasis
  
• A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
  ClinicalTrials.gov Identifier: NCT00442793 - Recruiting
  Anemia
  
• Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00364858 - Active, not recruiting
  Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
  
• Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
  ClinicalTrials.gov Identifier: NCT00188773 - Recruiting
  Insulin Resistance Syndrome X; Pancreatic Beta Cell Function
  
• Effectiveness of Combining Beta-Blocker Therapy and a Pacemaker Following a Heart Attack (The PACE-MI Trial)
  ClinicalTrials.gov Identifier: NCT00430612 - Recruiting
  Myocardial Infarction; Bradycardia; Heart Block
  
• Iron Balance Study of DFO and GT56-252 in Patients with Transfusional Iron Overload Secondary to Beta-Thalassemia
  ClinicalTrials.gov Identifier: NCT00069862 - Completed
  beta-Thalassemia
  
• Community - Associated Extended-Spectrum Beta-Lactamases (ESBL)
  ClinicalTrials.gov Identifier: NCT00363220 - Recruiting
  Infection; E Coli Infections; Klebsiella Infections; Proteus Infections
  
• Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
  ClinicalTrials.gov Identifier: NCT00536250 - Recruiting
  Impaired Glucose Tolerance; Pre-Diabetes; Childhood Obesity; Beta-Cell Function; Metabolic Syndrome
  
• Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
  ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
  Multiple Sclerosis
  
• Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
  ClinicalTrials.gov Identifier: NCT00198822 - Recruiting
  Vitamin A Deficiency
  
• Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan
  ClinicalTrials.gov Identifier: NCT00351650 - Recruiting
  Type I Diabetes
  
• A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00454389 - Recruiting
  Macular Degeneration
  
• The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00321321 - Recruiting
  Diabetes Mellitus, Type 2
  
• A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00260156 - Recruiting
  Diabetes Mellitus, Type 2
  
• Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
  ClinicalTrials.gov Identifier: NCT00344253 - Recruiting
  Uveitis, Intermediate; Macular Edema; Multiple Sclerosis
  
• Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00275418 - Recruiting
  Crohn's Disease
  
• Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
  ClinicalTrials.gov Identifier: NCT00311766 - Recruiting
  Epidermolysis Bullosa
  
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00380289 - Recruiting
  Essential Hypertension
  
• Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00568542 - Recruiting
  Ischemic Cardiomyopathy
  
• The CARO-Study; Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00128752 - Completed
  Health
  
• A Study of Long-Term Treatment With Deferasirox in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
  ClinicalTrials.gov Identifier: NCT00171171 - Completed
  Beta-Thalassemia; Hemosiderosis
  
• Use or Non-Use of Epoetin Beta in Patients Infected by Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00262379 - Recruiting
  Chronic Hepatitis C